Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 295-405-4 | CAS number: 92045-23-3 A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12°C to 5°C (10.4°F to 41°F).
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- reproductive toxicity, other
- Remarks:
- other: reproduction and developmental screening assay
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant, guideline study, available as unpublished report, no restrictions, fully adequate for assessment
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- Principles of method if other than guideline:
- guideline study
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- Hydrocarbons, C4, ethylene-manuf.-by-product
- EC Number:
- 270-691-3
- EC Name:
- Hydrocarbons, C4, ethylene-manuf.-by-product
- Cas Number:
- 68476-52-8
- IUPAC Name:
- Hydrocarbons, C4, ethylene-manuf.-by-product
- Reference substance name:
- C4 Crude Butadiene (low 1,3-Butadiene Content)
- IUPAC Name:
- C4 Crude Butadiene (low 1,3-Butadiene Content)
- Reference substance name:
- 25167-67-3, 64742-83-2, 68187-60-0, 68476-44-8, 68955- 28-2, 68956-54-7
- IUPAC Name:
- 25167-67-3, 64742-83-2, 68187-60-0, 68476-44-8, 68955- 28-2, 68956-54-7
- Details on test material:
- - Name of test material (as cited in study report): C4 Crude Butadiene (low 1,3-Butadiene Content)
- Supplier: Texas Petrochemicals, LP
- Substance type: Chemical stream
- Physical state: vapour
- Composition of test material, percentage of components: approx. composition: 10% 1,3-butadiene, 4% isobutane, 4% n-butane, 29% trans-2-butene, 29% 1-butene, 11% isobutylene, 12% cis-2-butene
- Lot/batch No.: lot # 268193
- Storage condition of test material: Supplied in cylinders and stored at approximately 4°C in an enclosed storage building, and kept at approximately 16°C during use.
Constituent 1
Constituent 2
Constituent 3
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD® (Sprague-Dawley) IGS BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Portage, Michigan, USA
- Age at study initiation: Approximately 8 weeks
- Weight at study initiation: Approximately 200-300 g (males) and 155-225 g (females)
- Housing: one per cage in stainless steel cages
- Diet: LabDiet® Certified Rodent Diet #5002 (PMI Nutrition International, St. Louis, Missouri, USA) in meal form ad libitum (except during exposures).
- Water: Municipal water ad libitum (except during exposures)
- Acclimation period: At least 1 week
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3 °C
- Humidity: 40-70%
- Air changes: 12-15 per hr
- Photoperiod: 12 hrs dark / 12 hrs light
IN-LIFE DATES: From: 24 October 2000 To: 29 November 2000
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- other: air
- Details on exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: 2 m3 stainless steel and glass Rochester-style exposure chambers (1.3m tall x 1.2m wide x 1.2m deep with a pyramidal top and bottom).
- Method of holding animals in test chamber: in stainless steel cages within the exposure chamber.
- Temperature, humidity in air chamber: 21.20 ± 1.67, 21.42 ± 0.46, 20.59 ± 0.47, 22.06 ± 0.49°C for 0, 2, 10 and 20 mg/L exposure groups respectively / 46.01 ± 3.36, 53.41 ± 6.93, 51.25 ± 7.86, 39.94 ± 7.32% for 0, 2, 10 and 20 mg/L exposure groups respectively.
- Air flow rate: approximately 450 L/minute
- Air change rate: 12-15 calculated air changes per hour.
TEST ATMOSPHERE
- Brief description of analytical method used: Gas chromatography
- Samples taken from breathing zone: yes - Details on mating procedure:
- - M/F ratio per cage: 1:1
- Length of cohabitation: until pregnancy occurred or 2 weeks
- Proof of pregnancy: vaginal plug / sperm in vaginal lavage referred to as day 0 of pregnancy
- After successful mating each pregnant female was caged individually - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The distribution of total hydrocarbons within the five sample locations in each chamber ranged from 91.35 to 104.94% of the mean reference value. The analytical concentrations for each chamber were 0.0, 2.17, 9.81 and 19.1 mg/L for the targeted concentrations of 0, 2, 10, and 20 mg/L, respectively.
- Duration of treatment / exposure:
- Two weeks prior to breeding, during breeding (up to two weeks), and continuing through day 19 of gestation. The dams were then allowed to deliver their litters, which were retained until postnatal day 4. The males were exposed for 36-37 days.
- Frequency of treatment:
- 6 hours/day, 7 days/wk
- Details on study schedule:
- as above
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0, 2, 10, 20 mg/L
Basis:
other: target concentration
- Remarks:
- Doses / Concentrations:
0.0, 2.17, 9.81, 19.1 mg/L
Basis:
analytical conc.
over 37 exposure days
- No. of animals per sex per dose:
- 12
- Control animals:
- yes, sham-exposed
- Details on study design:
- none
- Positive control:
- none
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: twice daily
- Cage side observations included: skin, fur, mucous membranes, respiration, nervous system function (including tremors and convulsions), animal behaviour, moribundity, mortality, and the availability of feed and water (males), clinical examinations were conducted on all females pre-exposure and weekly throughout the pre-breeding and breeding periods. Mated (sperm positive or plug positive) females received clinical examinations on gestation day (gd) 0, 7, 14, and 21. Females that delivered litters were subsequently evaluated on lactation day (ld) 0, 1, and 4. Females that failed to mate or failed to deliver litters were examined weekly. This examination included a careful, hand-held evaluation of the skin, fur, mucous membranes, respiration, nervous system function (including tremors and convulsions), swelling, masses, and animal behaviour.
DETAILED CLINICAL OBSERVATIONS: No
BODY WEIGHT: Yes
- Time schedule: at least once during the pre-exposure period and on the first day of exposure. Male body weights continued to be recorded weekly throughout the study and at termination. Females were weighed weekly during the pre-mating and mating periods. During gestation, females were weighed on days 0, 7, 14, and 20. Females that delivered litters were weighed on days 1 and 4 of lactation. Females that failed to mate or deliver a litter were not weighed during the gestation or lactation phases. Body weight gains were determined for the females on gestation days 0-7, 7-14, 14-20, 0-20, and lactation days 1-4.
FOOD CONSUMPTION: Yes
- Time schedule: Days 1-7, 7-14, and 28-36 for males (not measured during the two-week mating period due to co-housing). For females, weekly during the pre-breeding period, not measured during the mating period, following mating, gestation days 0-7, 7-14, 14-20, and on lactation days 1-4. Feed consumption was not recorded for females that failed to mate or deliver a litter.
WATER CONSUMPTION: No - Oestrous cyclicity (parental animals):
- not determined
- Sperm parameters (parental animals):
- A cross section through the approximate centre of both testes of control and high dose males was embedded in paraffin, sectioned at 5 μm and stained with modified periodic acid-Schiffs-hematoxylin. The presence and integrity of the 14 stages of spermatogenesis was qualitatively evaluated. Microscopic evaluation included a qualitative assessment of the relationships between spermatogonia, spermatocytes, spermatids and spermatozoa seen in cross sections of the seminiferous tubules. In addition, sections of both testes were examined for the presence of degenerative changes e.g., vacuolation of the germinal epithelium, multinucleated giant cells, a decrease in the thickness of the germinal epithelium, a preponderance of Sertoli cells, sperm stasis, inflammatory changes, mineralization, and fibrosis.
- Litter observations:
- Females examined for signs of parturition including signs of difficulty or unusual duration. All litters were examined as soon as possible after delivery. The lungs of any pups found dead during the initial examination were subjected to a flotation test to determine viability status at birth. The following information was recorded on each litter: the date of parturition, litter size on the day of parturition (day 0), the number of live and dead pups on postnatal days 0, 1, and 4, and the sex and the weight of each pup on postnatal days 1 and 4. Any visible physical abnormalities or behaviour changes in the neonates was recorded during the lactation period.
- Postmortem examinations (parental animals):
- see Repeated Dose Toxicity Section 7.5.3
- Postmortem examinations (offspring):
- gestation and postnatal survival indices, percent pre- and post-implantation loss
- Statistics:
- Adult body weights and feed consumption, maternal body weight gains, and pup body weights were analyzed by ANOVA. Gestation length, average time to mating (precoital interval) and litter size were analyzed using a nonparametric ANOVA. Pregnancy rates and mating, conception, fertility and gestation indices were analyzed by the Fisher exact probability test. Evaluation of the neonatal sex ratio was performed by the binomial distribution test. Post-implantation loss, pup survival indices, and other incidence data among neonates were analyzed using the litter as the experimental unit by a censored Wilcoxon test.
- Reproductive indices:
- mating, conception and fertility, time to mating, gestation length, litter size
- Offspring viability indices:
- as above
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
Details on results (P0)
Effect levels (P0)
- Dose descriptor:
- NOAEC
- Remarks:
- reproductive toxicity
- Effect level:
- 20 other: mg/L air (nominal), (20,000 mg/m3)
- Basis for effect level:
- other: no evidence of adverse effects on any measures of reproductive function at the highest dose tested (20 mg/L)
- Remarks on result:
- other: Generation not specified
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Gross pathological findings:
- no effects observed
Effect levels (F1)
- Dose descriptor:
- NOAEC
- Generation:
- F1
- Effect level:
- 20 other: mg/L air (nominal) (20,000 mg/m3)
- Sex:
- male/female
- Basis for effect level:
- other: Reproductive toxicity
- Remarks on result:
- other: Generation not specified
Target system / organ toxicity (F1)
- Critical effects observed:
- no
Overall reproductive toxicity
- Reproductive effects observed:
- no
Any other information on results incl. tables
There were no deaths or treatment-related clinical observations noted. No significant differences in parental body weights, body weight gains or feed consumption were observed at any dose level tested throughout the duration of the study. The only exception to this was a statistically identified increase in feed consumption noted for the 10 mg/L satellite females during the premating period (days 7-14). However, this increase was considered spurious, as feed consumption increases were not noted during subsequent gestation and lactation periods and similar changes in feed consumption were not observed at the highest exposure level of 20 mg/L. There were no treatment-related effects at any dose level on any of the reproductive parameters evaluated in this study. These included measures of reproductive performance (mating, conception and fertility, time to mating, gestation length, litter size), offspring survival (gestation and postnatal survival indices, percent pre- and post-implantation loss), pup body weight and pup sex ratio. The only statistically identified change in any of these parameters was an increase in post-implantation loss occurring only at the low-dose. This was considered a spurious finding, given the lack of a dose response. Of the 12 females mated in each group, the number of viable litters produced was 11, 11, 11, and 12 for the 0, 2, 10 and 20 mg/L exposure level groups, respectively. External morphological alterations observed in the pups were limited to a hernia observed in a single pup from the high dose group. Given the low incidence of this finding, it was considered spurious and unrelated to exposure.
Applicant's summary and conclusion
- Conclusions:
- Repeated inhalation exposure of C4 Crude Butadiene, to male and female rats at levels up to 20 mg/L produced no evidence of adverse effects on any measures of reproductive function.
- Executive summary:
Male and female Sprague Dawley rats were exposed to C4 Crude Butadiene by inhalation at levels of 0, 2, 10, or 20 mg/L (6h/day, 7 d/week) for two weeks prior to breeding, during breeding (up to two weeks), and continuing through day 19 of gestation. After birth pups were maintained until postnatal day 4. There were no treatment-related adverse effects on any measures of reproductive function. Based on these data, the NOAEC for reproductive toxicity was 20 mg/L (20,000 mg/m3), the highest concentration tested.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.